Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy.

EMBO Mol Med · 2019 · PMC6609910 · PMID 31273938

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Differences between G1 and G2 cohorts were also highly significant (Fig 1 A).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.